|
09/04/2025
|
07:00
|
Zenakine™ Technical Presentation & Share Price
|
RNS
|
|
08/04/2025
|
11:00
|
Croda Launches Zenakine™ at in-cosmetics Global
|
RNS
|
|
07/04/2025
|
17:34
|
Holding(s) in Company
|
RNS
|
|
03/04/2025
|
07:00
|
Warrant Exercise Notice and Total Voting Rights
|
RNS
|
|
26/03/2025
|
07:00
|
Half-year Report
|
RNS
|
|
20/03/2025
|
07:00
|
Warrant Exercise Notice and Total Voting Rights
|
RNS
|
|
26/02/2025
|
09:00
|
Holding(s) in Company
|
RNS
|
|
24/02/2025
|
07:00
|
Exercise of Warrants and Total Voting Rights
|
RNS
|
|
27/12/2024
|
11:00
|
Result of AGM
|
RNS
|
|
12/12/2024
|
14:45
|
Holding(s) in Company
|
RNS
|
|
04/12/2024
|
15:55
|
Posting of Annual Report and Notice of AGM
|
RNS
|
|
04/12/2024
|
15:54
|
Final Results
|
RNS
|
|
04/12/2024
|
07:00
|
Notice of Results
|
RNS
|
|
29/11/2024
|
11:00
|
Notice of Results
|
RNS
|
|
19/11/2024
|
07:00
|
Finalisation of commercial agreement with Croda
|
RNS
|
|
25/10/2024
|
16:29
|
Holding(s) in Company
|
RNS
|
|
23/10/2024
|
14:40
|
Integration update and share price movement
|
RNS
|
|
17/10/2024
|
07:00
|
Holding(s) in Company
|
RNS
|
|
16/10/2024
|
07:00
|
Issue of Equity and Total Voting Rights
|
RNS
|
|
11/10/2024
|
07:00
|
Acquisition and Financial Update
|
RNS
|
|
04/10/2024
|
14:02
|
Notice of Investor Meet Company Presentation
|
RNS
|
|
19/09/2024
|
07:00
|
Final testing of SkinBiotix by Croda completed
|
RNS
|
|
13/08/2024
|
12:49
|
Holding(s) in Company
|
RNS
|
|
08/08/2024
|
07:00
|
Holding(s) in Company
|
RNS
|
|
02/08/2024
|
07:00
|
Investment of £1.56m from new investors
|
RNS
|
|
29/07/2024
|
07:00
|
Full year trading update
|
RNS
|
|
29/07/2024
|
07:01
|
Appointment of Senior Croda VP as Board Advisor
|
RNS
|
|
23/07/2024
|
07:00
|
Closure of Convertible Bond Facility
|
RNS
|
|
22/07/2024
|
07:00
|
Conversion Notice and Total Voting Rights
|
RNS
|
|
15/07/2024
|
07:00
|
Notice of Business Update & Investor Presentation
|
RNS
|
|
28/06/2024
|
15:16
|
Conversion Notice and Total Voting Rights
|
RNS
|
|
18/06/2024
|
07:00
|
AxisBiotix Acne study reports positive data
|
RNS
|
|
29/05/2024
|
07:00
|
Conversion Notice and Total Voting Rights
|
RNS
|
|
11/04/2024
|
11:44
|
Holding(s) in Company
|
RNS
|
|
05/04/2024
|
07:00
|
Conversion Notice & Total Voting Rights
|
RNS
|
|
22/03/2024
|
07:00
|
Half-year Report
|
RNS
|
|
18/03/2024
|
11:36
|
Holding(s) in Company
|
RNS
|
|
18/03/2024
|
07:00
|
New research project and CSO to return to academia
|
RNS
|
|
12/03/2024
|
07:00
|
Conversion Notice and Total Voting Rights
|
RNS
|
|
08/03/2024
|
09:43
|
Notice of Results
|
RNS
|
|
28/02/2024
|
12:41
|
Conversion notice and alternative financing
|
RNS
|
|
27/02/2024
|
07:00
|
Positive Interim AxisBiotix Acne study results
|
RNS
|
|
20/02/2024
|
07:00
|
Dermatonics to launch Once Heel Balm in AMEA
|
RNS
|
|
09/02/2024
|
07:00
|
Conversion Notice and Total Voting Rights
|
RNS
|
|
06/02/2024
|
07:31
|
Dermatonics Full Year trading update
|
RNS
|
|
26/01/2024
|
07:00
|
Completion of Acquisition of Dermatonics
|
RNS
|
|
25/01/2024
|
07:00
|
Acquisition of Dermatonics
|
RNS
|
|
25/01/2024
|
07:00
|
£5.0m Convertible Bond Facility & First Drawdown
|
RNS
|
|
29/12/2023
|
10:49
|
Result of AGM
|
RNS
|
|
29/12/2023
|
08:13
|
Update on transaction timelines to early 2024
|
RNS
|